<bill session="115" type="h" number="6642" updated="2019-04-18T16:26:53Z">
  <state datetime="2018-07-31">REFERRED</state>
  <status>
    <introduced datetime="2018-07-31"/>
  </status>
  <introduced datetime="2018-07-31"/>
  <titles>
    <title type="official" as="introduced">To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.</title>
    <title type="display">To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.</title>
  </titles>
  <sponsor bioguide_id="B001248"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-07-31">
      <text>Introduced in House</text>
    </action>
    <action datetime="2018-07-31" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2018-08-03">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Health care costs and insurance"/>
    <term name="Medicaid"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2018-07-31T04:00:00Z" status="Introduced in House">This bill terminates certain limitations regarding drug rebates under Medicaid. Currently, the maximum rebate that drug manufacturers must pay under Medicaid for single-source and innovator multiple-source drugs is 100%&#160;of the average manufacturer price of the drug. The bill specifies that this limitation only applies to rebate periods that begin before January 1, 2019.</summary>
  <committee-reports/>
</bill>
